The Global Cell Dissociation Market size is projected to reach USD 561 million by 2026 from USD 282 million in 2021, at a CAGR of 14.7% during the forecast period. Factors such as growing government support for cell-based research, increasing research and development initiatives by biopharmaceutical companies and a growing focus on personalized medicine wherein cell dissociation plays a vital role are driving the growth of this market. However, the cell-based research activities are associated with high costs which is expected to restrain the market growth to certain extent.
Key Players:
Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Cytiva (a part of Danaher Corporation) (US), STEMCELL Technologies (Canada), Miltenyi Biotec (Germany), and PromoCell GmbH (Germany) etc.
Download PDF Brochure:
Global Cell dissociation Market Dynamics
DRIVER: Growth in research and development initiatives by biopharmaceutical companies
The top companies in the biopharmaceutical industry are focusing on R&D in various therapeutic areas to introduce new drugs in the market. Therefore, there have been heavy investments in various research activities such as clinical trials, efficacy studies, and toxicity studies. Most of these studies require tissue dissociation products in order to isolate cells from primary tissues. This is likely to boost the demand for cell dissociation products.
OPPORTUNITY: Emerging economies
Emerging economies, such as China, India, and Brazil, are expected to offer significant growth opportunities for players operating in the cell dissociation market. There has been a rise in the R&D projects in the life sciences field in these countries. For instance, pharmaceutical companies based in India are making significant investments in R&D to introduce new drugs into the market. Cadila Healthcare Ltd., an India-based pharmaceutical company, spent USD 113 million on R&D in 2020, an increase of 13% over 2019. Similarly, Biocon, another India-based pharmaceutical company, spent USD 58.79 million on R&D in 2020, an increase of 52% over 2019. Such investments are expected to increase the demand for cell dissociation products in the country.
Request Sample Pages:
CHALLENGE: Ethical concerns associated with research in cell biology
The cell biology research necessitates the use of animals and humans, as animal and human cells are used in gene therapy studies that involve the recombination of genes and stem cell research therapies. These animal and human cells are also used for in vivo toxicity and pharmacokinetic testing of drugs. This is because direct human or animal testing would be harmful and even fatal. Additionally, stem cell research studies use human embryos for clinical applications that often lead to their destruction. In order to monitor these activities, strict regulations have been formulated by ethical authorities in various countries across the globe. Authorities such as the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare products Regulatory Agency (MHRA), and Central Ethics Committee for Stem Cell Research (ZES), among others, have implemented stringent regulations for cell biology research. These ethical concerns and restrictions on the use of cells for research are limiting cell biology research to a great extent in various countries across the globe.
North America accounted for the largest share of the cell dissociation market in 2020
Based on the region, the cell dissociation market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the cell dissociation market. The large share of North America can primarily be attributed to the increasing research in pharmaceutical and biotechnology industries and the dominant presence of key market players in this region.
Frequently Asked Questions (FAQ):
· What is the projected market value of the global cell dissociation market?
· What is the estimated growth rate (CAGR) of the global cell dissociation market for the next five years?
· Who are the major players offering cell dissociation in the market?
· Which type segment of the global cell dissociation market is expected to witness the highest growth?
· Which end user segment is expected to grow at the highest CAGR during the forecast period?
Speak To Analyst:
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Comments